mRNA–LNP COVID-19 Vaccines: Insights from Conventional Immunisation & Drug-Targeting Principles
- Applying drug-targeting and immunisation principles to reduce off-target toxicity and improve tolerability of mRNA–LNP vaccines
- Designing formulations and dosing strategies that enable safe repeat administration without diminishing immune response
- Optimising LNP composition and delivery to enhance therapeutic durability and sustain protective efficacy over time